India’s data centre boom will be tested by power

India is preparing for one of its biggest digital infrastructure expansions. More than ₹3 lakh crore is expected to flow into data centres over the next four financial years, as artificial intelligence (AI), cloud computing and rising digital consumption reshape demand for computing capacity. Yet, behind this investment opportunity lies a less glamorous but far more fundamental requirement: electricity.

India's installed data centre capacity is expected to increase five-fold to approximately 7.5 gigawatts (GW) by March 2030, according to a CRISIL Ratings assessment released on November 3, 2026. The expansion will involve substantial capital investment, with developers seeking to build facilities capable of supporting increasingly demanding computing workloads.

India's data centre industry is preparing for a major expansion as demand for AI computing and cloud services accelerates

The projections underline India's growing importance in the global digital infrastructure landscape. However, they also raise a critical question: can the country's power infrastructure, transmission networks and supporting resources keep pace with the ambitions of data centre developers?

The answer could determine how successfully India converts the growing demand for digital services and AI computing into a sustainable investment opportunity.

The AI effect is changing the economics of data centres

Data centres are the physical backbone of the digital economy. They house the servers, storage systems and networking equipment that enable businesses, governments and individuals to access online services, process information and store data.

Their importance is increasing as organisations move more operations to the cloud and adopt data-intensive technologies. The emergence of generative AI has added another dimension to this demand.

Unlike conventional computing applications, many AI workloads require substantial processing power. Training and running sophisticated AI models involves large numbers of specialised processors working together. This increases the need for high-performance computing infrastructure, reliable electricity and advanced cooling systems.

The demand is already reflected in India's expanding data centre market. Cushman & Wakefield's India Data Centre Market H1 2026 report estimated operational capacity at nearly 1.8 GW, with a development pipeline of approximately 3.9 GW. The research also identified cloud adoption, AI workloads and enterprise digitalisation as important growth drivers.

CRISIL's projected expansion to 7.5 GW by March 2030 points to the scale of the next investment cycle.

The opportunity extends beyond companies operating data centres. Construction, electrical equipment, power generation, transmission, cooling technologies, networking and engineering services could all benefit from the expansion.

However, the industry is particularly capital-intensive. Developers must invest heavily in land, buildings, electrical systems, servers and cooling infrastructure before facilities begin generating meaningful revenue.

India's cost advantage is attracting investment

India has several advantages in competing for a larger share of the global data centre market.

According to CRISIL Ratings, development costs are approximately one-fifth lower than in several competing Asia-Pacific markets. More competitive land, construction and labour costs contribute to this advantage.

The cost difference is also reflected in rentals, which CRISIL estimates are 30–35% lower than in peer markets.

For international cloud service providers and hyperscalers, these economics make India an attractive destination for expanding computing infrastructure.

Policy support is adding to the investment proposition. The Union Budget 2026–27 proposed a tax holiday until 2047 for eligible foreign companies providing cloud services to global customers using data centre services in India, subject to specified conditions. The measure is intended to provide greater long-term tax certainty and encourage investment in domestic digital infrastructure.

India's ability to develop large campuses powered by renewable energy could further strengthen its position, particularly as international technology companies face increasing pressure to address the environmental impact of their operations.

But competitive costs and tax incentives can attract investment only up to a point. Developers ultimately need dependable electricity, adequate transmission capacity and the ability to commission projects on schedule.

Three cities face a significant power challenge

This is where the scale of India's planned expansion becomes particularly important.

CRISIL estimates that approximately three-fourths of the upcoming data centre capacity of around 6 GW is expected to be developed in Visakhapatnam, Mumbai and Hyderabad.

The concentration of investment in these locations could place considerable demands on their electricity infrastructure.

Reliable electricity supply and transmission infrastructure will be critical to India's data centre expansion

By fiscal 2030, the projected data centre capacity in Visakhapatnam could equal approximately 80% of its current peak power demand. The corresponding ratios for Mumbai and Hyderabad are estimated at around 60% and 20%, respectively.

These comparisons highlight the scale of the proposed infrastructure additions. They do not represent the projected percentage increase in each city's electricity consumption, but they indicate why grid connectivity and transmission augmentation will be critical.

A data centre requires a continuous and dependable power supply. Interruptions can affect servers, networks and the digital services hosted within the facility. Developers therefore need reliable grid connections, backup arrangements and adequate electrical infrastructure.

The challenge extends beyond supplying electricity to individual projects. Transmission networks must be capable of delivering the additional power to locations where large data centre campuses are being established.

The government has also recognised the growing electricity requirements of the sector. A Ministry of Electronics and Information Technology statement in March 2026 cited a Ministry of Power estimate of 13.56 GW in data centre electricity demand by 2031–32. A subsequent parliamentary update in July reported an additional projected load of 26.3 GW from AI data centres by the same period. The figures reflect different stated scopes and estimates, rather than a directly comparable revision of the same measure.

The larger message, however, is clear: data centre growth is becoming an increasingly important consideration in electricity planning.

Long-term contracts offer reassurance, but not immunity

Despite the infrastructure challenges, the demand outlook provides developers with an important financial advantage.

CRISIL reports that nearly half of upcoming capacity is already committed under long-term contracts. More than 95% of capacity currently under construction has also been contracted.

Existing facilities are operating at approximately 90% utilisation, indicating strong demand for available capacity.

An important development is the lengthening of customer contracts. Contract tenures have increased to 15–20 years from 10–12 years earlier.

Such agreements provide developers with greater revenue visibility and help reduce the risk of investing in facilities without confirmed customers. They also make it easier to plan financing and assess the potential returns from large projects.

However, the growing dependence on hyperscalers presents another challenge.

CRISIL expects hyperscalers to account for 75–80% of industry capacity by fiscal 2030, compared with 60–65% in fiscal 2026.

These large technology companies are important customers because of their substantial and sustained computing requirements. But their growing influence could also strengthen their bargaining power.

As more capacity becomes available and developers compete for large contracts, pressure on rentals could affect project returns. Long-term agreements provide revenue visibility, but they do not automatically protect developers from future pricing pressures or changes in customer requirements.

There is also the question of contract renewals. CRISIL notes that a meaningful track record of renewals has yet to be established in the industry. While high migration costs and the capital expenditure involved in replacing infrastructure could encourage customer retention, this remains an aspect to watch as the market matures.

The financial burden comes before the returns

The industry's investment cycle also creates a financing challenge.

Data centre projects require substantial capital expenditure well before they generate operating cash flows. According to CRISIL, investments typically precede cash generation by 24–36 months.

This means developers must carry significant financial commitments during construction and commissioning.

Debt levels are therefore expected to remain elevated over the medium term. As projects become operational and utilisation increases, stronger cash flows should gradually improve their financial position.

However, delays in obtaining approvals, securing power connections or completing construction could extend the period before revenue begins flowing.

Cost overruns or slower-than-expected customer demand could further weaken project economics.

The distinction between contracted capacity and operational capacity is important here. A signed customer agreement provides confidence in future demand, but the developer must still complete the facility, secure the necessary infrastructure and commission it before the contracted capacity can generate revenue.

Sustainability will be another test

Power availability is not the only resource challenge confronting the industry.

Data centres also require cooling systems to manage the heat generated by densely packed servers and computing equipment. As AI workloads increase, developers will need to accommodate higher power density and more advanced cooling technologies.

Water availability, land use and the environmental impact of large facilities will also require attention.

Higher computing intensity is increasing the importance of advanced cooling technologies in modern data centres

The government has begun addressing these issues through its policy framework. NITI Aayog's Data Centre Evaluation Framework, released in October 2026, encourages states to assess proposed investments across five areas: power and energy, water and cooling, siting and environmental sustainability, economic and strategic value, and policy, governance and implementation.

The framework recommends evaluating grid readiness, renewable energy and storage-backed power, as well as water availability and the impact on existing public resources.

These considerations are important because the economic value of a data centre investment cannot be measured only by the capital committed by its developer. Its long-term viability also depends on whether the supporting infrastructure and natural resources can sustain its operations.

The real test begins now

India's data centre opportunity is substantial. Growing AI adoption, cloud computing, enterprise digitalisation and rising data consumption provide a strong foundation for further investment.

The country also has competitive development costs, an increasingly supportive policy environment and growing interest from international technology companies.

But the next phase of growth will demand more than investment announcements and construction plans.

Power connectivity, transmission infrastructure, timely approvals, financial discipline and technological upgrades will determine whether the proposed capacity additions can be delivered efficiently.

For developers, the challenge will be to build facilities that remain commercially viable and technologically relevant over the long term. For policymakers and state governments, it will be to ensure that infrastructure planning keeps pace with private investment without placing unsustainable pressure on electricity, water and other resources.

India may be entering a major data centre investment supercycle. Whether it can turn that opportunity into lasting digital infrastructure strength will depend, to a considerable extent, on something far removed from the world of algorithms and artificial intelligence: its ability to deliver reliable power.

#DataCentres #IndiaDataCentres #ArtificialIntelligence #GenerativeAI #DataCentreInfrastructure #PowerInfrastructure #EnergyTransition #CloudComputing #DigitalIndia #DataCentreInvestment

Medicine price controls face a test as cancer treatment remains costly

Cancer treatment can be financially punishing long before a patient completes a course of medicines. The cost of a drug, the price printed on its pack and the amount ultimately charged by a hospital can be very different. For families already coping with the physical and emotional strain of cancer, understanding these differences is not an academic exercise. It can determine whether treatment remains affordable.

A new round of government-directed price revisions promises relief for patients buying several anti-cancer medicines. Yet the revised prices also expose a limitation in the way affordability is measured: reducing the price of some medicines does not necessarily make the most expensive treatments accessible, nor does it settle questions about the mark-ups added along the healthcare supply chain.

The issue has gained urgency following two developments. The National Pharmaceutical Pricing Authority (NPPA) has published revised maximum retail prices (MRPs) for non-scheduled anti-cancer medicines, with the new prices due to take effect on November 9, 2026. Separately, the Supreme Court has questioned the Centre and private hospitals over medicine pricing and the large gaps between procurement costs and the amounts charged to patients.

Together, these developments raise a larger question: can medicine price controls deliver meaningful relief if substantial costs remain outside their reach?

Sharp cuts, but not across the board

The NPPA’s revised price list, based on information received from companies up to October 28, 2026, shows that the impact varies considerably between products. Some generic cancer medicines face substantial reductions, while the listed prices of several high-cost patented brands remain unchanged. The list is an important record of the price revisions, but it should not be mistaken for a measure of what every patient will save on an entire course of treatment.

The difference is striking in the examples reported by The Economic Times and its pharmaceutical industry publication, ETPharma. Their reporting identifies Keytruda, a pembrolizumab injection marketed by MSD, among the high-priced medicines whose MRP remains unchanged. The revised list puts its 100 mg injection at ₹2,16,500 per vial. Tagrisso, an osimertinib treatment marketed by AstraZeneca, is also unchanged at ₹4,16,492.48 for a pack of 30 tablets.

These figures do not, by themselves, establish what a particular patient will pay after discounts, assistance programmes or hospital billing arrangements. Nor does an unchanged MRP automatically establish that a price is unlawful. They do, however, illustrate the limits of a price revision when some of the costliest products see no reduction in their listed retail prices.

The contrast with selected generic products is substantial. In the NPPA list, Mylan’s MyTera, an abiraterone acetate 250 mg tablet pack of 120, falls from ₹16,865 to ₹5,105.50 — a reduction of about 69.7%. Khandelwal Laboratories’ ABIRAT, containing the same active ingredient and pack size, falls from ₹36,088.81 to ₹4,064.48, a reduction of about 88.7%.

These examples show the potential for meaningful savings. They also underline why comparisons must be made carefully: brands containing the same active ingredient can start from very different MRPs, and the price of a pack is not the same as the total cost of treatment. Patients should discuss suitable alternatives with their treating doctors rather than switch medicines on price alone.

What does a price cap actually control?

The latest intervention concerns trade margins on 137 non-scheduled anti-cancer medicines, with the government setting a 30% cap and directing revised MRPs for covered formulations. The distinction between scheduled and non-scheduled medicines matters because the regulatory mechanisms are not identical.

In its March 2026 statement, the Department of Pharmaceuticals said that ceiling prices for 131 anti-cancer drugs had resulted in an average reduction of around 21% against the prices fixed under the National List of Essential Medicines, with estimated annual savings of approximately ₹294 crore. The government also pointed to subsidised treatment in public hospitals, the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana scheme, Jan Aushadhi outlets and AMRIT pharmacies as other routes to improving access. These are government-reported figures and measures; they do not establish the savings experienced by every household.

A trade-margin cap and a ceiling on the price of a medicine are not interchangeable. A margin cap seeks to limit the difference permitted within the distribution chain under the relevant framework. It does not necessarily mean that the underlying price charged by a manufacturer will fall by the same proportion. This distinction is particularly important for patented medicines, where the scope for reducing a final price may differ from that for generic products facing competition.

The policy’s impact must therefore be judged product by product. It is too early to conclude that the latest revisions have failed: they are due to take effect on 9 November. But the unchanged prices in the list make it equally difficult to claim that the measure will make all high-cost cancer treatment affordable.

The hospital bill is a separate challenge

The Supreme Court’s hearing on October 27, 2026, brought another part of the problem into focus: the difference between the price at which medicines or medical consumables are procured and the amount charged to patients.

According to reports by Moneycontrol and IANS, the bench questioned the Centre over the regulatory framework and cited an example of a drip line bought for ₹15 but billed to a patient at ₹250. The court also heard an account involving a cancer injection that a medical distributor said could be procured for ₹11,000 but was reportedly charged at ₹1.30 lakh by a hospital.

These were examples raised during proceedings, not evidence that every hospital applies comparable mark-ups. Hospital representatives argued that institutions must maintain round-the-clock facilities, ensure the quality of medicines and cover operating expenses. The bench questioned whether such costs justified steep differences in medicine prices and remarked that hospitals could not survive through “dacoity”.

The court reserved its verdict. Its observations should not be presented as a final ruling, but they sharpen the policy question: how should legitimate healthcare costs be recovered, and how should patients be protected from excessive or poorly explained charges?

The hospital-billing issue is related to, but distinct from, the NPPA’s revised MRPs. A lower MRP may help a patient purchasing a covered medicine, but it does not automatically resolve how hospitals price medicines and consumables, or how they disclose procurement costs, discounts and charges. Equally, an unchanged MRP does not prove that a hospital’s charge is excessive. Those questions require scrutiny of the product, the transaction and the applicable rules.

Measuring affordability at the point of care

For patients, the meaningful measure of success is not simply how many prices have been revised. It is whether the medicine they need is available, whether an appropriate lower-cost alternative exists, and what they must actually pay to receive treatment.

That calls for transparent, product-level price information; clear bills that distinguish medicines from other hospital charges; effective monitoring of compliance; and accessible information about legitimate generic alternatives and patient-assistance programmes. Public procurement and institutional negotiations may also matter where expensive patented medicines remain beyond the reach of many households.

None of these measures removes the need to fund research, maintain reliable medicine supplies or operate safe hospitals. But affordability cannot be judged only from the perspective of manufacturers, distributors or healthcare providers. It must also account for household incomes and the consequences when a patient cannot meet the bill.

The NPPA’s revised list offers tangible relief on some products, and those reductions should not be dismissed. But unchanged prices for several costly brands, alongside unresolved questions about hospital mark-ups, show why a price cap is only one part of a larger response.

The real test begins when the revised prices take effect: whether the savings reach patients, whether billing practices are transparent and whether people facing cancer can obtain appropriate treatment without being pushed into financial distress. Until affordability is assessed at that point of care, lower prices on paper will remain an incomplete measure of progress.

#AffordableHealthcare #DrugPricing #CancerCare #CancerTreatment #HealthcareCosts #NPPA #MedicinePrices #HospitalBilling #PatientRights #HealthcarePolicy

The government admits hospital pricing needs closer scrutiny

The Centre's acknowledgement of excessive hospital pricing has brought a longstanding problem into sharper focus. The challenge now is to protect patients without compromising access to medicines and medical care.

A hospital bill can contain far more than the cost of a doctor's consultation, a bed or a surgical procedure. Medicines, implants, injections and medical consumables can add substantially to the final amount. For patients undergoing cancer treatment or recovering from major surgery, these expenses can accumulate over weeks or months.

The problem is not simply that healthcare is expensive. It is that patients may have little information about the prices of the products used in their treatment, few opportunities to compare alternatives and limited freedom to question charges when their health is at stake.

Hospital bills are becoming a patient rights issue, as cancer drug mark-ups expose India's healthcare pricing dilemma
(AI generated representative image)

The Union government has acknowledged this concern before the Supreme Court, describing excessive pricing of medicines and consumables by hospitals as malpractice. In an affidavit reported by The Times of India on 23 October, the Centre highlighted mark-ups of 170% to 700% or more on some anti-cancer medicines and 100% to 1,000% or more on certain hospital consumables.

The figures are striking. But the more important question is what they reveal about the relationship between patients, hospitals and the businesses supplying healthcare products.

When patients cannot easily question the bill

A patient buying a medicine from a retail pharmacy may have an opportunity to compare brands, ask about alternatives or visit another shop. That freedom can disappear inside a hospital, particularly during an emergency or an extended course of treatment.

Patients and their families may not know which consumables are medically necessary, whether equivalent products are available or how much the hospital paid for them. When a doctor recommends a procedure and the hospital arranges the supplies, questioning individual prices can feel difficult.

The Centre's affidavit reportedly recognises this imbalance in bargaining power and access to information. It also raises concerns about hospitals purchasing medicines from manufacturers offering higher trade margins and subsequently charging patients the printed maximum retail price (MRP).

This distinction matters. A product sold at its MRP is not necessarily being sold illegally. But a substantial gap between the hospital's procurement price and the amount billed to a patient raises legitimate questions about pricing transparency and the way financial incentives influence purchasing decisions.

The concern extends beyond medicines. Consumables used during surgery, treatment and routine hospital care may appear relatively inexpensive individually, yet their cumulative cost can become significant.

For families paying directly for treatment, the final bill may therefore reflect not just the medical care received, but also the pricing arrangements governing the products used to provide it.

Cancer medicines expose the pricing dilemma

The issue becomes particularly serious when the medicines are required to treat life-threatening illnesses. Cancer patients may need several rounds of treatment, making the cost of medicines a recurring financial burden rather than a one-time expense.

The Centre has announced a proposed intervention to cap trade margins on selected non-scheduled anti-cancer medicines at 30% of their MRP. It expects the measure to reduce prices by 20% to 70% and save patients approximately ₹2,500 crore annually. These are government estimates, not savings already achieved. The medicines covered are to be identified through a separate process.

The Supreme Court, however, has questioned why the response should be confined to cancer medicines. During hearings in September and October, the court drew attention to substantial differences between the prices of medicines and medical supplies at different stages of the supply chain. It pressed the government to consider broader measures.

The Centre has argued that pricing interventions must account for distribution costs and the need to maintain supplies, including in remote areas. The court's scrutiny reflects a competing concern: a pricing system must not leave patients carrying an excessive financial burden simply because they cannot negotiate the cost of treatment.

The problem is also more complicated than setting a single percentage. Medicines, implants and consumables have different costs, supply chains and distribution requirements. A policy that works for one category may not be suitable for another.

A problem that predates the latest intervention

The current debate follows a Supreme Court judgment delivered on 4 March 2025 in Siddharth Dalmia and another versus Union of India and others.

The case concerned allegations that private hospitals compelled patients to buy medicines, devices, implants and consumables from hospital-linked pharmacies at inflated prices. The Court asked state governments to consider appropriate policy measures, while cautioning against interventions that could unreasonably discourage private healthcare providers. It did not rule that the allegations in the petition had been proved.

This distinction is important. The challenge is not to assume that every private hospital engages in malpractice, but to establish clear and enforceable rules that protect patients wherever unreasonable pricing occurs.

There is also a regulatory gap between medicines covered by existing price controls and other products used in hospitals. The Centre's own account acknowledges that more information is needed to understand the scale of the problem and design appropriate interventions.

The Supreme Court's next hearing in the current proceedings is scheduled for 27 October 2026.

Transparency must become part of patient care

Price regulation alone may not resolve every problem. Patients also need to know what they are being charged for, whether a prescribed product has a suitable alternative and whether they can obtain it elsewhere without compromising treatment.

Hospitals should be able to explain their charges clearly. Patients should receive itemised bills that distinguish medicines, consumables, procedures and other services. Where a hospital requires a particular product, the medical reason should be understandable to the patient or caregiver.

Regulators, meanwhile, need reliable data on procurement prices and actual billing practices. Without it, they risk introducing rules that are difficult to enforce or that fail to address the largest sources of excessive charges.

The government has acknowledged the problem. The court has demanded a wider examination of medicine pricing. The real test will be whether these developments lead to practical safeguards that patients can see in their bills.

Healthcare is not an ordinary consumer purchase. People often seek it when they have little time, limited information and no easy way to walk away. Protecting them requires more than recognising that prices can be excessive. It requires a system in which charges are transparent, rules are enforceable and the cost of treatment does not become an additional source of distress.

#HealthcareCosts #HospitalOvercharging #HealthcareAffordability #PatientRights #MedicalInflation #CancerTreatment #MedicinePrices #HealthcareReform #SupremeCourtOfIndia #HealthcareInIndia

From pump repairs to industrial problem-solving, PSUCHE is carving out its niche

An industrial pump rarely attracts attention when it works as expected. But when it fails repeatedly, struggles to handle the material it was selected for, or becomes difficult to replace, it can turn into a costly operational problem. For manufacturers, the challenge is not simply to repair the equipment. It is to understand why it failed and find a solution that works under actual operating conditions.

This is the problem-solving approach that, according to Vishal Garg, proprietor of PSUCHE Pumps & Systems, has shaped the company’s business since its establishment in 2018.

“The company began with pump selection, servicing and troubleshooting for critical, semi-critical and general industrial applications. Over time, experience gained from repairing pumps made by different manufacturers exposed recurring problems involving design limitations, unsuitable applications, material compatibility and mechanical failures,” said Garg.

PSUCHE's stated evolution from repair work to retrofit solutions and the manufacture of its own pump range provides the central thread of its business journey. Rather than treating a failed pump as an isolated maintenance issue, the company seeks to use that experience to develop equipment better suited to the demands of industrial processes.

It is a proposition that places application knowledge at the centre of the business.

Learning from failures

In industrial operations, choosing a pump involves more than matching a product to a required flow rate. The nature of the liquid, its chemical properties, operating pressure, temperature and the demands of the process can all influence the choice of equipment and materials.

A mismatch can result in repeated breakdowns, maintenance requirements and disruption. Replacing a failed unit with an identical model may not resolve the underlying problem if the original selection was unsuitable for the application.

“Our experience in servicing and troubleshooting pumps from different manufacturers gave us a practical starting point for addressing such challenges. Our approach is to draw on this experience when modifying equipment, developing retrofit solutions and manufacturing our own products,” said Garg.

The distinction matters. Repair work addresses an immediate problem; engineering-led problem-solving attempts to understand and correct its cause. For customers, the potential value lies in finding a technically appropriate solution rather than repeatedly dealing with the consequences of equipment failure.

Building a broader product proposition

The company’s product range covers several pump technologies used in different industrial applications. These include peristaltic hose pumps, electronically operated double diaphragm (EODD) pumps, air-operated double diaphragm (AODD) pumps, magnetic-drive centrifugal pumps, gear and single-screw pumps, canned motor pumps, and vertical long-shaft pumps with lengths of up to three metres.

This breadth gives PSUCHE a platform to address varied pumping requirements rather than concentrating on a single equipment category.

The technologies serve different purposes. Peristaltic pumps move fluids through a flexible hose, while diaphragm pumps use a moving membrane to transfer liquid. Gear and single-screw pumps use positive-displacement mechanisms, making them relevant to applications requiring controlled handling of certain fluids. Magnetic-drive and canned motor designs, meanwhile, can be considered where containing the pumped liquid and limiting leakage are important design priorities.

The appropriate choice depends on the process, fluid properties, operating conditions and the equipment's design limits. A broad catalogue alone does not guarantee suitability, but technical knowledge across multiple pump types can help a supplier evaluate alternatives when a standard replacement is not adequate.

According to Garg, the strategic opportunity is to combine the product range with the company's troubleshooting and retrofit experience, allowing PSUCHE to approach customer requirements as engineering problems rather than simply product enquiries.

Import substitution as a business opportunity

One of PSUCHE’s principal offerings is import-substitute pumps. The company identifies organisations including Tata Steel's Khopoli operations, Elementis Specialties, TechNova Imaging Systems, Gujarat Insecticides, Exide Industries, Balmer Lawrie and Jubilant Ingrevia among its customers for these pumps.

This proposition addresses a recognisable industrial procurement challenge. When an imported pump is difficult to source, has a long delivery period or belongs to an obsolete product line, an alternative may help a plant avoid prolonged dependence on the original supplier.

The Indian pump industry has an established role in replacement equipment and import substitution. The Indian Pump Manufacturers' Association (IPMA) has highlighted the importance of domestic pumps and responsive after-sales service in industrial applications. Industry commentary has also highlighted the role of localisation, material improvements and design customisation in strengthening the domestic sector.

For PSUCHE, the opportunity is not merely to offer an Indian-made alternative. A replacement must also meet the relevant technical requirements, fit the installation, work with the process fluid and demonstrate dependable performance. Customers may need drawings, performance curves, material specifications, testing records and service support before approving a substitute for an existing pump.

The company's ability to meet these requirements consistently is central to building confidence in its import-substitution proposition.

A service-led route to market

The company’s approach to attracting customers is relatively direct. “We invite prospective buyers to share pump datasheets, details of existing equipment or descriptions of application challenges so that we can evaluate the requirement and propose a technically suitable solution,” said Garg.

This suggests a consultative, application-led sales model. Instead of relying exclusively on standard product enquiries, the company seeks to understand the customer's operating problem before considering whether servicing, modification, retrofitting or a replacement pump is appropriate.

Such an approach is particularly relevant when a customer faces recurring failures, high maintenance requirements, obsolete equipment or extended import lead times.

It also creates an opportunity to build relationships through technical support. A successful repair or replacement can provide a starting point for further work at the same facility.

According to Garg, the company has handled pump repair requirements for organisations including ISRO, Balmer Lawrie and Exide Industries. These reported engagements indicate experience across a range of industrial requirements.

Serving diverse industrial requirements

PSUCHE identifies the chemical, pharmaceutical, oil and gas, fertiliser, aerospace, steel and specialty chemical industries among the sectors it serves.

These industries present demanding pumping requirements, from material compatibility and containment to reliability under particular operating conditions. However, the technical and regulatory requirements differ substantially between applications. A solution suitable for one process cannot automatically be assumed to meet the requirements of another.

This diversity makes application assessment important to the company's proposition. It also raises the need for clear technical documentation, appropriate testing and evidence that a particular pump is suitable for its intended duty.

For a smaller or specialist supplier, competing effectively may depend less on matching every large manufacturer's scale and more on identifying applications where technical responsiveness, customised solutions and replacement support matter to the buyer. This is a potential basis for PSUCHE to differentiate itself in the market.

Turning engineering experience into a lasting advantage

The company’s business model brings together three activities: troubleshooting existing equipment, developing solutions for problematic applications and supplying pumps designed to address identified requirements.

The combination offers a clear strategic logic. Servicing can reveal recurring problems; engineering and modification can help address them; and manufacturing creates an opportunity to turn the resulting knowledge into a product offering.

As Garg puts it, “Industrial customers ultimately need more than a pump that fits. They need equipment that performs reliably in the conditions for which it was selected, backed by a supplier capable of responding when problems arise.”

PSUCHE’s value proposition lies in combining practical pump servicing and troubleshooting experience with application-specific engineering, retrofit solutions and its own range of industrial pumps, helping customers address demanding pumping requirements with technically suitable solutions.

The opportunity for the company is to make its experience with pump failures the starting point for a more differentiated engineering business. Its ability to carve out a lasting niche will depend on translating that experience into reliable products, documented customer outcomes and solutions that meet the demands of real industrial operations.

#PSUCHEPumps #IndustrialPumps #PumpEngineering #IndustrialInnovation #ImportSubstitution #MakeInIndia #PumpMaintenance #ProcessEngineering #EngineeringSolutions #IndianManufacturing

लोकतंत्र या धनतंत्र? मस्क का यह विरोधाभास समझ से परे है

न्यू यॉर्क टाइम्स की यह रिपोर्ट एक बार फिर अमेरिकी लोकतांत्रिक प्रणाली में पैसे के बेहिसाब प्रभाव को उजागर करती है। 

एलन मस्क, जिन्होंने कभी राजनीति से दूरी बनाने और "बहुत कम खर्च करने" की बात कही थी, आज 2026 के मिडटर्म चुनावों में $366 मिलियन से अधिक की फंडिंग देकर रिपब्लिकन पार्टी के सबसे बड़े तारणहार और डोनर बनकर उभरे हैं। 

जब आम नागरिक वोट की ताकत से बदलाव की उम्मीद करता है, तब एक अकेले अरबपति द्वारा सुपर पीएसी (Super PACs) के जरिए करोड़ों डॉलर झोंक देना चुनावी निष्पक्षता पर गंभीर सवाल खड़े करता है।

मस्क अक्सर सोशल मीडिया पर व्यवस्था में पारदर्शिता, निष्पक्षता और फ्री स्पीच की वकालत करते हैं। लेकिन जब वे खुद पर्दे के पीछे से इतनी बड़ी वित्तीय ताकत का इस्तेमाल करके जनमत और चुनावी जमीन को प्रभावित करने की कोशिश करते हैं, तो उनकी बातें खोखली नजर आती हैं। 

ऐसे में उनके इस कदम पर यह कहावत सटीक बैठती है कि -- "जिनके अपने घर शीशे के होते हैं, वे दूसरों के घरों पर पत्थर नहीं फेंका करते।"

यदि आप खुद प्रणाली को अपनी दौलत से प्रभावित कर रहे हैं, तो दूसरों को नैतिकता का पाठ पढ़ाना बंद करना होगा। 

लोकतंत्र केवल सबसे अमीर लोगों के हितों की रक्षा का जरिया नहीं बन सकता।

Elon Musk’s claims about Starlink connecting India’s remote villages should be taken with a pinch of salt

Elon Musk’s promise is compelling: bring high-speed internet to places where conventional broadband cannot reach, connecting remote villages, isolated communities and people left on the wrong side of the digital divide. His Starlink satellite network could help make that possible. But there is a difference between making a connection available and delivering reliable, affordable internet to everyone who needs it.

Recent reports from Kenya, research into satellite-network capacity in the United States and complaints from customers raise questions that India should consider as Starlink seeks to enter one of the world’s largest and most price-sensitive internet markets.

The concern is not that satellite broadband has no place in India. It is that Musk’s promise should be measured against what Starlink can deliver in practice—not simply the number of countries it serves or the reach of its satellites.

For a country with vast rural regions, difficult terrain and sharply different levels of digital access, that distinction matters.

Kenya offers a warning for India

Kenya provides a particularly relevant case study because it shows how a satellite internet service can expand rapidly and still struggle to accommodate new customers in areas where demand is concentrated.

According to Business Daily’s report of 6 October 2026, Starlink’s 27,616 fixed internet subscriptions represented about 1 per cent of Kenya’s 2.84 million fixed broadband connections by the end of June 2026. Yet new residential sign-ups remained restricted in eight counties, including Nairobi, Mombasa and Kiambu.

The lesson is not that a network with tens of thousands of subscribers cannot succeed. Kenya’s figures describe the countrywide customer base, not the number of users sharing a single satellite or local service area. The problem reported by the newspaper is that available capacity in particular areas was insufficient to accept all prospective customers.

For India, the implications deserve attention.

A satellite service may reach a village that has no fibre connection. But what happens if demand grows quickly? Will additional capacity arrive in time? Will users experience significant slowdowns at busy hours? Will new customers be placed on waiting lists? And will the service remain affordable for households that have limited spending power?

These are not arguments against satellite technology. They are questions that any responsible assessment of its potential should address.

When a connection becomes expensive

The remote American state of Alaska offers another perspective on the gap between connectivity and affordability. 

A Starlink Residential Max order there carries a $1,500 demand surcharge, in addition to $20 for shipping and handling. That brings the total due at checkout to $1,520, while the monthly service fee remains $130.

An Alaska-based user on X (Scott @bitcoinregulate) also complained about the high upfront cost and reported download speeds of 20 Mbps and upload speeds of 5 Mbps.

The screenshot and complaint should be treated as an individual example, not proof of typical Starlink prices or performance. The circumstances behind the surcharge and the user’s connection speeds would need to be independently verified.

Nevertheless, the example raises a question relevant to India: does the promise of connecting underserved communities translate into a service those communities can actually afford?

India’s internet market has been shaped by low-cost mobile data and fierce competition among established operators. A satellite service does not necessarily need to match every mobile plan to be useful. In a remote location where no viable alternative exists, a more expensive connection may still be worth paying for.

But affordability cannot be measured simply by whether a customer can place an order. Equipment costs, recurring subscriptions, installation, network performance and the availability of cheaper alternatives all matter.

For a school, health centre or small business in an isolated area, reliability may be just as important as download speed. A connection that becomes inconsistent when it is most needed can undermine the very purpose for which it was purchased.

What the research says about capacity

A Washington Post analysis published on 18 July 2025 examined the limits of satellite broadband as more customers share available network resources.

The report discussed research led by telecommunications expert Sascha Meinrath. In a hypothetical model, the researchers estimated that 419 Starlink customers within an area the size of Tacoma, Washington, could push performance below a US government benchmark for reliable broadband uploads.

That finding needs careful interpretation. It was a model, not a universal limit established by testing every Starlink service area. The researchers acknowledged that their assumptions required further testing, and the report noted that Starlink’s continuing network expansion and technical improvements could change the picture.

The analysis also recognised where satellite internet is most valuable: rural and remote areas where fibre networks are impractical or prohibitively expensive to build.

That is the essential distinction. Starlink can be a technological breakthrough for communities that have few alternatives while still facing challenges when large numbers of people depend on the same limited resources.

All broadband networks have capacity constraints. The question is how those constraints affect customers, how quickly providers can respond and whether consumers are told what to expect.

India’s decision should be based on evidence

The debate over Starlink’s entry into India has increasingly become entangled with Musk’s public criticism of the country’s regulatory process.

In October 2026, Musk accused powerful business interests of obstructing Starlink’s launch and directed pointed remarks at Reliance Industries chairman Mukesh Ambani. India’s government rejected the suggestion that the process was biased.

According to Reuters’ report of 9 October 2026, Telecom Minister Jyotiraditya Scindia said Starlink and other satellite operators were at a similar stage in the regulatory process, with security compliance and spectrum allocation still outstanding.

Musk’s allegations do not, by themselves, establish that a rival business caused the delay. Equally, a fair and transparent regulatory system should explain its requirements clearly and avoid leaving applicants in unnecessary uncertainty.

The government must assess satellite operators according to applicable rules. Those rules should protect legitimate security interests while allowing competition and innovation. Starlink, in turn, must demonstrate that it can meet its obligations and deliver the service it promises.

Musk has also pledged to make Starlink affordable in India. As Reuters reported on 11 October 2026, the company faces a market in which mobile data is already inexpensive by international standards.

That makes the challenge especially significant. India does not simply need another internet provider. It needs services that address genuine gaps in connectivity, offer good value and perform reliably for the people who use them.

Starlink could be particularly useful in remote settlements, mountainous regions, islands, maritime operations and disaster-hit areas. But its suitability will vary by location, demand, price and available alternatives.

The right question is not whether India should believe Musk or reject him. It is whether the company can demonstrate, with clear evidence, that its service will meet the needs of the communities it says it wants to connect.

A promise is not the same as a result

There is good reason for India to explore satellite broadband. No single technology can solve every connectivity problem, and satellite networks can help extend internet access where conventional infrastructure falls short.

But Starlink’s promise should not exempt it from the scrutiny applied to any other provider. The company must be judged on its actual coverage, capacity, pricing, reliability and ability to serve customers as demand grows.

Kenya’s waiting lists, the questions raised by capacity modelling and the Alaska checkout example do not prove that Starlink cannot connect India’s remote villages. They show why sweeping promises deserve careful examination.

For India, the objective should be straightforward: better connectivity for people who need it, at a cost they can bear, with service reliable enough to make a meaningful difference.

Musk may be able to connect places that conventional networks struggle to reach. But reaching a village is only the beginning. Keeping its people connected affordably and reliably is the real test.

#Starlink #ElonMusk #StarlinkIndia #SatelliteInternet #RuralConnectivity #DigitalIndia #InternetAccess #DigitalDivide #IndiaTechPolicy #DataSovereignty

Elon Musk’s Starlink demands expose a double standard | The security questions Elon Musk cannot dismiss |

 

The security questions Musk cannot dismiss

India’s concerns about Starlink are not merely theoretical. Two incidents in November and December 2024 brought the issue into sharp focus, raising questions about the use of satellite communications equipment in Indian territory before the company had received permission to provide commercial services.

On 25 November 2024, the Indian Coast Guard intercepted a Myanmar fishing boat near the Andaman and Nicobar Islands carrying approximately 5,500 kg of methamphetamine, which the government described as its largest-ever drug seizure of this kind. The Defence Ministry’s official account of the operation recorded the recovery of a portable Inmarsat satellite phone.

Subsequent police reporting described a Starlink device among the equipment recovered from the vessel. Investigators suspected that the smugglers had used satellite internet to navigate at sea, and police sought information from SpaceX about the device’s purchaser and registration details. The reported quantity was approximately 6,000 kg, with an estimated value of ₹36,000 crore.

Hindustan Times reported on the suspected use of Starlink for navigation, while Reuters reported on the police demand for information and Musk’s subsequent response.

The distinction between the initial official account and the subsequent police investigation is important. The Coast Guard’s initial statement identified an Inmarsat phone; later reporting described the Starlink equipment. The suspected use of Starlink was an investigative finding, not proof that SpaceX had knowingly assisted criminal activity.

The following month, Indian security forces recovered a device bearing the Starlink logo during an operation in Manipur. The equipment was found alongside weapons and ammunition in a region affected by prolonged ethnic violence and insurgency.

Musk responded on X that Starlink’s satellite beams were turned off over India and had never been active there. His statement was consistent with the fact that Starlink had not been authorised to provide commercial services in the country.

But the issue did not end with that denial.

On 3 January 2025, The Guardian reported that sources from armed groups and law enforcement in Manipur said Starlink devices had been used in several areas to access the internet during government-imposed shutdowns. According to the report, a source linked to the Meitei separatist group People’s Liberation Army said the group had initially used a device in Myanmar and subsequently discovered that it also worked across the border in Manipur.

The newspaper reported that the devices were believed to have been brought into India from Myanmar and that it could not establish how many armed groups had access to the technology.

These reports do not establish that Musk deliberately enabled smugglers or insurgents to use Starlink. Nor do they conclusively establish that the seized equipment was functioning in every reported incident. But they raise questions that a responsible regulator cannot ignore: can unauthorised equipment be activated across borders, can its use be detected, and can access be restricted when a serious security threat emerges?

Those questions are especially relevant to India, which has a long and sensitive international border, faces drug trafficking and insurgency challenges, and must manage communications during emergencies.

Three safeguards are not unreasonable demands

India needs satellite broadband. Remote villages, islands, mountainous regions and areas with limited terrestrial infrastructure could benefit considerably from reliable satellite connectivity. Starlink should have the opportunity to compete for that market.

But commercial access must be accompanied by enforceable safeguards.

First, Indian traffic and data must be handled in accordance with Indian law. India’s Department of Telecommunications specifies requirements for satellite communications services that include routing Indian traffic through gateways established in the country. Its official GMPCS authorisation guidance sets out relevant gateway, privacy and security conditions.

Second, Indian law enforcement and security agencies must have access to lawful interception and monitoring mechanisms. Satellite internet providers should not be exempt from the legal obligations that apply to telecommunications operators merely because their networks use satellites rather than terrestrial towers and cables. Such powers must, in turn, be exercised within the law and subject to appropriate safeguards.

Third, the government must have an effective and legally defined mechanism to restrict or suspend service in a specified area during a genuine emergency, where a lawful order requires it. This is particularly important if satellite connectivity can otherwise bypass a local communications shutdown imposed during serious violence or a security crisis. The precise technical and contractual arrangements needed to achieve this must be established before commercial launch, rather than assumed to exist.

These requirements are not an argument against satellite internet. They are a framework for ensuring that a powerful foreign communications network can operate responsibly within India.

The government must also be transparent about the scope of its demands, protect legitimate user privacy and avoid using shutdown powers arbitrarily. National security should not become a blanket justification for suppressing lawful communication. But neither should the benefits of connectivity be used to dismiss genuine security risks.

That is the balance India must strike.

Welcome Starlink, but on India's terms

Musk’s argument would be stronger if it focused on how Starlink can meet these requirements, improve connectivity and offer Indian consumers a competitive service. Instead, his public attacks have shifted attention towards allegations of political interference for which he has not presented publicly verifiable evidence.

India is not obstructing Starlink simply because it is an American company, nor is it protecting domestic telecom firms from fair competition. The regulatory framework appears to be applied consistently. However, authorities still need to explain the delays more clearly and provide a transparent path to approval.

But a licence to operate in other countries is not a substitute for Indian authorisation. Nor does a company’s technological sophistication give its owner the right to decide which national rules are acceptable.

The question is not whether India should welcome satellite internet. It should. The question is whether India can ensure that a network operating within its borders remains accountable to its laws, including during a national emergency.

Starlink is welcome in India. The price of admission is compliance with India's lawful, transparent and enforceable requirements, just as it would be for any other telecommunications provider.

#ElonMusk #Starlink #IndiaNationalSecurity #India #DataSovereignty #CyberSecurity #DigitalSovereignty #SatelliteInternet #IndiaTechPolicy #NationalSecurity

Sovereignty, Security, and Real Statistics: Why Elon Musk’s Starlink narrative on India falls short

Elon Musk has taken to X (formerly Twitter) to launch a series of sharp complaints against the Indian Government. His central claim? That Starlink’s commercial entry into India is being deliberately blocked by 'oligarchs' who want to keep rural Indians in the dark. Musk has even gone so far as to call the regulatory delay a 'crime against the people of India'.

However, a closer look at the actual rules, network data, and statements from Musk’s own team paints a very different picture. Far from running a unfair system, India is simply applying its national security laws to all satellite broadband providers equally.

Here is a clear look at why Musk’s narrative does not match reality.

1. It Is Security and Sovereignty, Not a Blockade

The primary reason Starlink cannot sell services in India today is not cronyism — it is compliance.

Under Indian telecommunications law, any satellite company operating within the country must meet strict national security standards:

• Local Data Storage: All internet data belonging to Indian users must stay inside Indian borders.
  
  
• Lawful Intercept: Ground infrastructure must allow Indian law enforcement agencies to monitor communications legally when required by court orders or national security protocols.
  
  
• No Unregistered Hardware: Foreign-bought satellite dishes and terminals cannot operate on Indian soil without proper tracking.

Netizen A.N.S. Prasad cut through the noise on X, writing: "India is not blocking Starlink. It is licensing Starlink on sovereign terms... What remains is security clearance and spectrum, the same pending gate for Jio Satellite and Bharti-backed Eutelsat OneWeb. No private company issues that clearance. The Government of India does... Do not rename a sovereign queue a crime against the Indian people."

What makes Musk’s accusations even stranger is that his own team is actively working through this process. Speaking at the India Mobile Congress, SpaceX Vice President Lauren Dreyer publicly confirmed that Starlink has already built 20 gateway sites (ground stations that connect satellites to the internet) across India and created custom, India-specific security controls.

If Starlink is already building ground stations and preparing its network to meet these security checks, calling a standard safety review a 'crime' is simply inaccurate.

2. Playing with Numbers: India’s True Coverage Realities

Musk’s posts often point to uncovered villages to suggest that India has a massive connectivity crisis that only Starlink can fix. But Indian tech experts have called out his selective use of numbers.

Commenting on Musk's statistical framing, observer Abhinav Agarwal posted: "Saying '11,256' villages sounds a lot. But it is a way of lying with numbers. What if the handle had said, '1.7% of India's villages have no 4G coverage'? That wouldn't fit the narrative, right?"

The data backs this up. According to official figures from the Department of Telecommunications (DoT), over 98% of India’s 600,000+ villages already have active internet access, driven by massive 4G and 5G network rollouts.

The small fraction of villages that currently lack mobile signals are primarily located in:

• Highly remote or heavily forested areas.
  
  
• Sparse border regions like Kutch or remote parts of Rajasthan.
  
  
• Highly sensitive border terrain near China in Arunachal Pradesh.

In sensitive border zones, unmonitored satellite links pose severe national security risks. As Agarwal noted, satellite communications have been abused during past national emergencies, such as the 2008 Mumbai attacks, where handlers used foreign satellite connections to guide attackers. India’s insistence on verifying satellite security before turning on the switch is a necessary safety measure, not a political trick.

3. The Pricing Mismatch: Who Is Starlink Actually For?

There is another practical issue that Musk’s posts gloss over: affordability.

India has some of the cheapest mobile data rates in the world, costing users roughly ₹10 to ₹15 per gigabyte. The average rural consumer in India relies on affordable $3-a-month 4G/5G mobile plans.

Expecting lower-income rural households to purchase a hardware dish costing tens of thousands of rupees alongside a monthly bill of several thousand rupees is economically unrealistic. Starlink will likely serve high-end corporate accounts, ships, aircraft, and defense outposts — not replace general rural mobile networks.

4. Spectrum Laws Prove Rules Are Not Rigged

The claim that India's Government acts solely to protect domestic operators is disproved by recent spectrum policy decisions.

Domestic telecom operators initially argued that satellite spectrum should be auctioned off to the highest bidder — a move that would have favoured heavy-spending local companies. However, the Indian Government aligned with international standards and opted for administrative allocation. This means satellite spectrum will be handed out at fixed government rates rather than competitive auctions, a decision that directly benefits satellite operators like Starlink.

UPDATE FROM THE MINISTRY OF COMMUNICATIONS, GOVERNMENT OF INDIA

India’s regulatory framework for satellite communication services is fair and non-discriminatory

Posted On: 08 OCT 2026 (9:19AM by PIB Delhi): A post is being circulated in social media regarding the fairness of India’s regulatory framework for satellite communication services and suggesting that it is being applied in a discriminatory manner. The Government has put in place a fair and non-discriminatory authorisation framework for all telecommunication services, including satellite communication services. 

Under this, telecom licences have been granted to three Global Mobile Personal Communication by Satellite services based on non-geosynchronous satellite orbit based satellite communications, as part of its commitment to enable provision of satellite communication services in India. 

Under the terms and conditions of license, every such licensee is required to demonstrate compliance with security conditions. This is aimed at ensuring that services provided meet various security requirements to ensure safety of all users and their data. 

Security assessment as part of this process is currently underway in respect of all the three licensees. As and when this process is completed for a licensed entity, it may proceed to the next step of seeking assignment of spectrum. At present, all the three entities are at broadly the same regulatory stage. 

As such, the suggestion that the framework or its application is unfair or discriminatory is baseless and misconceived.

The Bottom Line

India is not closing its doors to foreign technology or space-based internet. It is simply enforcing a basic rule: if you want to operate inside a sovereign nation, you must comply with its local laws and security checks.

Starlink holds its license, its Vice President confirms that local infrastructure is being set up, and final clearances are moving through standard government channels. Trying to bypass national security reviews by framing regulatory queues as 'oligarch chokepoints' may generate engagement on social media, but it does not change the facts on the ground.

#StarlinkIndia, #ElonMusk, #DigitalIndia, #TelecomNews, #NationalSecurity, #SpaceX, #DoT, #TechDebate, #SatcomIndia, #SovereignRights